Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?

Saved in:
Bibliographic Details
Published inEuropean journal of internal medicine Vol. 87; pp. 98 - 99
Main Authors Qiu, Mei, Ding, Liang-Liang, Zhan, Ze-Lin, Zhou, Hai-Rong
Format Journal Article
LanguageEnglish
Published Netherlands 01.05.2021
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0953-6205
1879-0828
DOI:10.1016/j.ejim.2021.01.009